United States · FDA National Drug Code directory
Labetalol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51407-615_4f9b6911-a34d-5d03-e063-6294a90a7b82
- Product NDC
- 51407-615
- Form
- TABLET, FILM COATED
- Composition / generic term
- Labetalol Hydrochloride
- Labeler
- Golden State Medical Supply, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180620
- Source listing expiry
- 20271231
Source-listed ingredients
- LABETALOL HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (51407-615-01) · 51407-615-01
- 500 TABLET, FILM COATED in 1 BOTTLE (51407-615-05) · 51407-615-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →